Illumina and Synamatix have signed an agreement to work closely together to provide users of the Illumina Genome Analyzer with enhanced solutions for the analysis and mining of data. Dr. Omoshile Clement, Senior Product Manager of Informatics and Systems at Illumina stated, "We are pleased to have Synamatix in the Illumina Connect program and to help our customers address the considerable challenges they face in sequencing data management and analysis."
Synamatix General Manager, Dr. Arif Anwar said, "The breadth and scale of applications that are now possible with the Illumina Genome Analyzer is revolutionising contemporary molecular biology. We are looking forward to working closely with the Illumina community on a range of exciting genome and transcriptome sequencing projects in Asia, Europe and North America."
Currently, most solution providers only move, store and archive data, whereas Synamatix goes a step further by enabling data analysis, mutation identification and prioritisation of results to help researchers get closer to biological answers.
About Synamatix
The fundamental technology underlying Synamatix R&D is the proprietary "SynaBASE" platform. Applications built upon this database platform exhibit significant improvement in analysis scalability, sensitivity and performance. Synamatix is a privately held bioinformatics company whose primary activities are ongoing R&D related to its core technology, and the support of its user base in the USA, Europe, Asia and Australia.
Contact
Patricia Chan
Marketing and Communications
Synamatix Sdn Bhd
enquiries @ synamatix.com
Synamatix Joins Illumina Connect Software Support Program to Provide Integrated Bioinformatics Solutions for the Genome Analy


